Middle East & Africa Glycomic Therapeutics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis ByClass (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), Mode of Action [Inhibits Neuraminidase, Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate, Erythropoietin & Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthas Interleukin 1 and 2 and 3, Beta & Gamma Interferons, and Others]

No. of Pages: 197    |    Report Code: BMIRE00027509    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Glycomic Therapeutics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Glycomic Therapeutics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Glycomic Therapeutics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing research in glycomics
  • 5.1.2 Rising demand for personalized medicine
  • 5.1.3 Technological advancements in glycan analysis
5.2 Market Opportunities
  • 5.2.1 Expanding application in cancer treatments
  • 5.2.2 Growth in precision medicine market
  • 5.2.3 Development of glycan-based therapeutics
5.3 Future Trends
  • 5.3.1 Focus on glycan biomarker discovery
  • 5.3.2 Advancements in glycosylation research
  • 5.3.3 Integration with gene therapies
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Glycomic Therapeutics Market Regional Analysis

6.1 Middle East & Africa Glycomic Therapeutics Market Overview
6.2 Middle East & Africa Glycomic Therapeutics Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Glycomic Therapeutics Market Forecast Analysis

7. Middle East & Africa Glycomic Therapeutics Market Analysis – by Class

7.1 Isolated and Synthetic
  • 7.1.1 Overview
  • 7.1.2 Isolated and Synthetic: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Glycomic Therapeutics Market Analysis – by Structures

8.1 Glycoproteins
  • 8.1.1 Overview
  • 8.1.2 Glycoproteins: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Targeting Sialic Acid
  • 8.2.1 Overview
  • 8.2.2 Targeting Sialic Acid: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Proteoglycans
  • 8.3.1 Overview
  • 8.3.2 Proteoglycans: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Targeting Glycosaminoglycans
  • 8.4.1 Overview
  • 8.4.2 Targeting Glycosaminoglycans: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Glycosylphosphatidylinositol-Anchored Proteins & Heparin Based Glycans
  • 8.5.1 Overview
  • 8.5.2 Glycosylphosphatidylinositol-Anchored Proteins & Heparin Based Glycans: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Targeting Glycosphingolipids
  • 8.6.1 Overview
  • 8.6.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Glycomic Therapeutics Market Analysis – by Indications

9.1 Thrombosis & Chemoprophylaxis
  • 9.1.1 Overview
  • 9.1.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Anaemia
  • 9.2.1 Overview
  • 9.2.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Anti-Adhesive & Anti-Inflammatory
  • 9.3.1 Overview
  • 9.3.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cataracts
  • 9.4.1 Overview
  • 9.4.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Gaucher's Disease
  • 9.5.1 Overview
  • 9.5.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 MPS-1 & IV
  • 9.6.1 Overview
  • 9.6.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Cancer
  • 9.7.1 Overview
  • 9.7.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Alzheimer's Disease
  • 9.8.1 Overview
  • 9.8.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9.9 Influenza Type A & B
  • 9.9.1 Overview
  • 9.9.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Glycomic Therapeutics Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Glycomic Therapeutics Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Class
    • 10.1.1.1.2 South Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Structures
    • 10.1.1.1.3 South Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Indications
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Class
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Structures
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Indications
  • 10.1.1.3 UAE: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Class
    • 10.1.1.3.2 UAE: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Structures
    • 10.1.1.3.3 UAE: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Indications
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Class
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Structures
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Indications

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Glycomic Therapeutics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Protalix Biotherapeutics
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BioMarin Pharmaceutical Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Genzyme Corporation (Sanofi)
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Bayer AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 GlaxoSmithKline plc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 F. Hoffmann-La Roche Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Middle East & Africa Glycomic Therapeutics Market

  1. Protalix Biotherapeutics                               
  2. BioMarin Pharmaceutical Inc.                    
  3. Genzyme Corporation (Sanofi)                 
  4. Bayer AG                                                            
  5. GlaxoSmithKline plc.                                      
  6. F. Hoffmann-La Roche Ltd                           
middle-east-and-africa-glycomic-therapeutics-market